• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors.

作者信息

Jones R M, Hjorth S A, Schwartz T W, Portoghese P S

机构信息

Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, USA.

出版信息

J Med Chem. 1998 Dec 3;41(25):4911-4. doi: 10.1021/jm9805182.

DOI:10.1021/jm9805182
PMID:9836606
Abstract
摘要

相似文献

1
Mutational evidence for a common kappa antagonist binding pocket in the wild-type kappa and mutant mu[K303E] opioid receptors.野生型κ和突变型μ[K303E]阿片受体中存在共同κ拮抗剂结合口袋的突变证据。
J Med Chem. 1998 Dec 3;41(25):4911-4. doi: 10.1021/jm9805182.
2
Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.吲哚苯部分被取代的纳曲吲哚类似物的合成、阿片受体结合及生物活性测定。
J Med Chem. 1998 Jul 16;41(15):2872-81. doi: 10.1021/jm980083i.
3
Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinans.5'-取代的17-环丙基甲基吡啶并[2',3':6,7]吗啡喃的合成、阿片受体结合及功能活性
Bioorg Med Chem Lett. 2003 Feb 10;13(3):529-32. doi: 10.1016/s0960-894x(02)00934-4.
4
Characterization of BU09059: a novel potent selective κ-receptor antagonist.新型强效选择性κ受体拮抗剂BU09059的特性研究
ACS Chem Neurosci. 2014 Mar 19;5(3):177-84. doi: 10.1021/cn4001507. Epub 2014 Jan 28.
5
Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists.诺布啡诺（norBNI）类似物与野生型及突变型μ和κ阿片受体的结合：κ拮抗剂药效基团和定位成分的分子识别位点
J Med Chem. 2000 Apr 20;43(8):1573-6. doi: 10.1021/jm000059g.
6
Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.7-芳基吗啡喃的合成。探究阿片δ受体选择性的“定位”要求。
J Med Chem. 1998 Jul 30;41(16):3091-8. doi: 10.1021/jm9802214.
7
Diprenorphine has agonist activity at opioid kappa-receptors in the myenteric plexus of the guinea-pig ileum.二丙诺啡对豚鼠回肠肌间神经丛中的阿片κ受体具有激动活性。
Eur J Pharmacol. 1987 May 7;137(1):85-9. doi: 10.1016/0014-2999(87)90185-3.
8
The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors.阿片类拮抗剂纳曲吲哚对δ阿片受体的选择性。
J Pharm Pharmacol. 1990 May;42(5):358-9. doi: 10.1111/j.2042-7158.1990.tb05428.x.
9
Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus.通过阿片受体的定点诱变研究羟吗啡酮和纳曲酮衍生配体的选择性：探索“地址”识别位点。
J Med Chem. 2001 Mar 15;44(6):857-62. doi: 10.1021/jm000381r.
10
BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.BU74，一种具有强效κ阿片受体激动作用和延迟阿片拮抗作用的复杂阿片碱衍生物。
Eur J Pharmacol. 2005 Feb 21;509(2-3):117-25. doi: 10.1016/j.ejphar.2004.12.035.

引用本文的文献

1
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands.κ阿片受体药理学：新型检测方法与配体
Front Pharmacol. 2022 Apr 21;13:873082. doi: 10.3389/fphar.2022.873082. eCollection 2022.
2
κ-Opioid receptor antagonism reverses heroin withdrawal-induced hyperalgesia in male and female rats.κ-阿片受体拮抗作用可逆转海洛因戒断诱导的雄性和雌性大鼠痛觉过敏。
Neurobiol Stress. 2021 Apr 14;14:100325. doi: 10.1016/j.ynstr.2021.100325. eCollection 2021 May.
3
The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach.
强啡肽与κ阿片受体在精神分裂症和重性抑郁症中的作用：一种转化研究方法。
Handb Exp Pharmacol. 2022;271:525-546. doi: 10.1007/164_2020_396.
4
Computational insights into the subtype selectivity and "message-address-efficacy" mechanisms of opioid receptors through JDTic binding and unbinding.通过 JDTic 的结合和解离，计算洞察阿片受体的亚型选择性和“信息-地址-功效”机制。
Acta Pharmacol Sin. 2018 Mar;39(3):482-491. doi: 10.1038/aps.2017.132. Epub 2017 Oct 19.
5
Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships.通过构效关系研究阿片类全拮抗剂 AT-076 对孤啡肽、κ、μ 和 δ 阿片受体的配体识别。
Sci Rep. 2017 Oct 16;7(1):13255. doi: 10.1038/s41598-017-13129-1.
6
Pharmacodynamic Relationships between Duration of Action of JDTic-like Kappa-Opioid Receptor Antagonists and Their Brain and Plasma Pharmacokinetics in Rats.大鼠中JDTic样κ-阿片受体拮抗剂的作用持续时间与其脑和血浆药代动力学之间的药效学关系
ACS Chem Neurosci. 2016 Dec 21;7(12):1737-1745. doi: 10.1021/acschemneuro.6b00249. Epub 2016 Oct 4.
7
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif.利用四氢异喹啉基序通过磺酰胺限制增强κ-阿片受体拮抗剂探针ML140的效力。
Bioorg Med Chem. 2015 Jul 15;23(14):3948-56. doi: 10.1016/j.bmc.2014.12.033. Epub 2014 Dec 23.
8
K303⁶·⁵⁸ in the μ opioid (MOP) receptor is important in conferring selectivity for covalent binding of β-funaltrexamine (β-FNA).μ阿片受体（MOP）中的K303⁶·⁵⁸对于赋予β-芬太尼酰四氢巴马汀（β-FNA）共价结合的选择性很重要。
Eur J Pharmacol. 2015 Feb 5;748:93-100. doi: 10.1016/j.ejphar.2014.11.028. Epub 2014 Dec 4.
9
Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonists.通过在阿片受体晶体结构和定点突变研究中对接来研究 6α-和 6β-N-杂环取代的纳曲胺衍生物的结合模式：“信息-地址”概念在开发μ阿片受体选择性拮抗剂中的应用。
Bioorg Med Chem. 2013 Nov 1;21(21):6405-13. doi: 10.1016/j.bmc.2013.08.042. Epub 2013 Sep 4.
10
Opioid receptor selectivity profile change via isosterism for 14-O-substituted naltrexone derivatives.通过 14-O-取代纳曲酮衍生物的等排体改变阿片受体选择性特征。
Bioorg Med Chem Lett. 2013 Jul 1;23(13):3719-22. doi: 10.1016/j.bmcl.2013.05.027. Epub 2013 May 16.